Altria’s tobacco companies’ regulatory science team focuses on developing lower-risk tobacco products for adult tobacco consumers, as part of a comprehensive approach to reduce the harm caused by tobacco products.
Our team generates the scientific evidence needed to demonstrate that certain tobacco products result in lower exposure to harmful compounds or are lower risk when compared to conventional cigarettes. We have been at the forefront of developing new methodologies to assess the health impact of potentially reduced harm tobacco products.
Our scientists published extensively in this area and our work is often cited by other scientists including those at the FDA. We've also been involved in groundbreaking research to help the company and the science move forward. We share this research on this website where we invite scientific review from and dialogue with scientists and the public health and regulatory communities.